| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NASDAQ | Common Stock, par value $0.0001 per share ("Common Stock") | Conversion of derivative security | +8.15M | 8.15M | Jul 1, 2024 | See footnotes | F1, F2, F3, F4 | |||
| transaction | NASDAQ | Common Stock | Award | $40M | +2.5M | +30.69% | $16.00 | 10.6M | Jul 1, 2024 | See footnotes | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NASDAQ | Series B Redeemable Convertible Preferred Stock | Conversion of derivative security | $0 | -20M | -100% | $0.00 | 0 | Jul 1, 2024 | Common Stock | 4.28M | See footnotes | F1, F2, F3, F4 | |
| transaction | NASDAQ | Series B-2 Redeemable Convertible Preferred Stock | Conversion of derivative security | $0 | -5.34M | -100% | $0.00 | 0 | Jul 1, 2024 | Common Stock | 1.14M | See footnotes | F1, F2, F3, F4 | |
| transaction | NASDAQ | Series C Redeemable Convertible Preferred Stock | Conversion of derivative security | $0 | -12.7M | -100% | $0.00 | 0 | Jul 1, 2024 | Common Stock | 2.73M | See footnotes | F1, F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the "Common Stock") (the "IPO"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3. |
| F2 | Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO. |
| F3 | The securities reported herein are held by AyurMaya Capital Management Fund, LP (the "AyurMaya Fund"). AyurMaya Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager. |
| F4 | The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. |
The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Alan Colowick, Senior Managing Director of Matrix Capital Management Company LP, an affiliate of the Investment Manager, currently serves on the board of directors of the Issuer.